Biohaven (BHVN) Enterprise Value (2021 - 2026)
Biohaven (BHVN) posted Enterprise Value of -$347.8 million for Q1 2026, down 8.99% sequentially from -$319.1 million in Q4 2025, and down 7.77% YoY from -$377.1 million in Q1 2025.
Biohaven (BHVN) Enterprise Value (2021 - 2026) Analysis & Trends
Biohaven has reported Enterprise Value for 6 years, with the latest figure at -$347.8 million in Q1 2026.
- Quarterly Enterprise Value fell 7.77% year-over-year to -$347.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$347.8 million (down 7.77% YoY) and the FY2025 annual result came in at -$319.1 million, up 34.33% from the prior year.
- Enterprise Value fell to -$347.8 million in Q1 2026 per BHVN's latest filing, from -$319.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$23.2 million in Q2 2022 and troughed at -$486.0 million in Q4 2024.
- A 5-year average of -$275.7 million and a median of -$319.1 million in 2025 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 85.99% in 2022, down 2798.06% in 2022.
- Over 5 years, Enterprise Value stood at -$465.3 million in 2022, then increased by 17.95% to -$381.8 million in 2023, then slipped by 27.28% to -$486.0 million in 2024, then surged by 34.33% to -$319.1 million in 2025, then retreated by 8.99% to -$347.8 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$347.8 million, -$319.1 million, and -$260.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | -267.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -267.87 Mn |
| Mar 31, 2026 | -347.82 Mn |
| Dec 31, 2025 | -319.14 Mn |
| Sep 30, 2025 | -260.22 Mn |
| Jun 30, 2025 | -404.98 Mn |
| Mar 31, 2025 | -322.75 Mn |
| Dec 31, 2024 | -485.99 Mn |
| Sep 30, 2024 | -378.82 Mn |
| Jun 30, 2024 | -436.95 Mn |
| Mar 31, 2024 | -283.42 Mn |
| Dec 31, 2023 | -381.82 Mn |
| Sep 30, 2023 | -111.73 Mn |
| Jun 30, 2023 | -188.03 Mn |
| Mar 31, 2023 | -186.58 Mn |
| Dec 31, 2022 | -465.34 Mn |
| Sep 30, 2022 | -50.67 Mn |
| Jun 30, 2022 | -23.21 Mn |
| Mar 31, 2022 | -40.26 Mn |
| Dec 31, 2021 | -16.06 Mn |
| Sep 30, 2021 | -361.70 Mn |